VIRGINIA RETIREMENT SYSTEMS ET Al Takes $21.55 Million Position in DaVita Inc. $DVA

Key Points

• Virginia Retirement Systems ET Al has acquired a new stake in DaVita Inc., purchasing 151,307 shares valued at approximately $21.55 million during the second quarter.
• In recent analyst ratings, Bank of America downgraded DaVita's price target from $145 to $140, while Barclays reduced their target from $160 to $149, indicating a cautious outlook for the company.
• DaVita's most recent earnings report revealed $2.95 earnings per share, exceeding estimates, with a notable 6.1% increase in revenue year-over-year, highlighting its financial performance despite market challenges.

VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in DaVita Inc. (NYSE:DVA - Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 151,307 shares of the company's stock, valued at approximately $21,554,000. VIRGINIA RETIREMENT SYSTEMS ET Al owned 0.20% of DaVita at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. National Pension Service boosted its stake in DaVita by 74.3% during the 1st quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after acquiring an additional 84 shares during the last quarter. Y.D. More Investments Ltd acquired a new stake in shares of DaVita in the 1st quarter worth about $35,000. Ameritas Advisory Services LLC bought a new position in DaVita in the 2nd quarter valued at about $47,000. NewEdge Advisors LLC grew its position in DaVita by 20.8% in the 1st quarter. NewEdge Advisors LLC now owns 511 shares of the company's stock valued at $78,000 after buying an additional 88 shares in the last quarter. Finally, University of Texas Texas AM Investment Management Co. bought a new position in shares of DaVita during the 1st quarter valued at about $83,000. 90.12% of the stock is currently owned by institutional investors.

Insider Activity at DaVita

In other news, insider James O. Hearty sold 2,351 shares of DaVita stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total value of $352,650.00. Following the transaction, the insider owned 26,038 shares of the company's stock, valued at $3,905,700. This trade represents a 8.28% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on DVA shares. Weiss Ratings restated a "hold (c+)" rating on shares of DaVita in a research report on Wednesday, October 8th. Bank of America reduced their price objective on shares of DaVita from $145.00 to $140.00 and set an "underperform" rating for the company in a research report on Wednesday, September 10th. Barclays reduced their price objective on shares of DaVita from $160.00 to $149.00 and set an "equal weight" rating for the company in a research report on Thursday, October 9th. Truist Financial set a $140.00 price objective on shares of DaVita in a research report on Tuesday, October 14th. Finally, Wall Street Zen lowered shares of DaVita from a "buy" rating to a "hold" rating in a research report on Saturday, October 11th. Four equities research analysts have rated the stock with a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Reduce" and a consensus target price of $153.25.

DaVita Price Performance

NYSE DVA opened at $125.79 on Monday. The firm has a market capitalization of $8.99 billion, a price-to-earnings ratio of 12.37, a price-to-earnings-growth ratio of 0.90 and a beta of 1.13. The company has a 50 day simple moving average of $132.49 and a 200-day simple moving average of $138.20. DaVita Inc. has a 52-week low of $122.93 and a 52-week high of $179.60.

DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating the consensus estimate of $2.70 by $0.25. The firm had revenue of $3.38 billion for the quarter, compared to analyst estimates of $3.36 billion. DaVita had a net margin of 6.35% and a return on equity of 369.39%. The company's revenue for the quarter was up 6.1% on a year-over-year basis. During the same quarter last year, the firm earned $2.00 earnings per share. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. On average, analysts predict that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.

Want to see what other hedge funds are holding DVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DaVita Inc. (NYSE:DVA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.